Supriya Lifescience Ltd Share Price

Overview

Supriya Lifescience Ltd share price is currently ₹786.31, down by - ₹6.13 (0.77%) from its previous closing price of ₹792.44. The share price has declined -5.43% over the past month and gained 20.95% over the past year. The stock's 52-week low and high are ₹0.00 and ₹1,068.25, respectively. Supriya Lifescience Ltd has a market capitalisation of ₹ 6,480.00 Cr. The share price was last updated on 25 Aug 2026, 03:29 PM IST.

Supriya Lifescience Ltd

SUPRIYA

₹0.00

- ₹6.13

0.77%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 03:29:57 pm IST

Market Data

Open Price

₹794.37

Prev. Close

₹792.44

₹785.42

Day Low

₹810.70

Day High

₹0.00

52 Week Low

₹1,068.25

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

31.90

Sector PE

42.03

PB Ratio

6.35

Sector PB

5.82

EPS

24.65

Dividend Yield

0.14

Today's Volume

116.314 K

5 Day Avg. Volume

154.637 K

PEG Ratio

0.55

Market Cap.

₹ 6,480.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 50% at ₹1/Share	04-Sep-2025	05-Sep-2025
DividendsFinal Dividend of 40% at ₹0.8/Share	20-Sep-2024	21-Sep-2024

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Abakkus Flexi Cap Fund - Regular Plan - Growth	5.37 Lac	5.37 Lac no change
ITI Large & Mid Cap Fund - Regular Plan - Growth	1.28 Lac	1.28 Lac no change
Quantum Small Cap Fund - Regular Plan - Growth	1.07 Lac	1.07 Lac no change
ITI ELSS Tax Saver Fund - Regular Plan - Growth	91.52 k	91.52 k no change
Motilal Oswal Nifty Microcap 250 Index Fund - Regular Plan - Growth	70.15 k	68.01 k (3.04%)

Show all holdings

About Supriya Lifescience Ltd 👋

Supriya Lifescience Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs). The Company is primarily engaged in the manufacturing of bulk drugs and pharmaceutical chemicals. The Company exports its products in the antihistamine, anesthetics and anti-asthma therapy categories to approximately 86 countries. The Company's product portfolio consists of approximately 38 API products that offer remedies in therapeutic segments, such as antihistamines, analgesics, vitamins, anesthetics and anti-asthmatics, among others. Its products include Chlorphenamine Maleate, Pheniramine Maleate, Brompheniramine Maleate, Dexchlorpheniramine Maleate, Mepyramine / Pyrilamine Maleate, Dexbrompheniramine Maleate, Cetirizine DiHCL, Diphenhydramine HCL, Bisoprolol Fumarate, Nicorandil, Mecobalamin, Hydroxocobalamin Sulfate, Hydroxocobalamin Acetate, and Hydroxocobalamin Hydrochloride, among others. The Company has manufacturing facilities located in Maharashtra.